ArticleBioorganic & medicinal chemistry letters2026
Triscationic bolaamphiphilic QACs - optimizing antibacterial therapeutic indices.
Article in Bioorganic & medicinal chemistry letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- SuperBola Cationic Biocides with an Extended Bolaamphiphilic Structure: How Much Is Too Much?ACS infectious diseases · 2026Article
- Extending the architecture of bolaamphiphilic disinfectants: an investigation of octenidine and isooctenidine analogs.RSC medicinal chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Due to the relentless advance of bacterial resistance mechanisms, there exists an urgent need to develop novel surface disinfectants that eradicate a wide range of pathogenic bacteria. Our efforts in this arena have focused on optimization of potency, resistance-to-resistance, and safety. Herein, we report the efficient and modular construction of a series of triscationic quaternary ammonium compounds with a bolaamphiphilic architecture, based on a versatile phloroglucinol core where the cationic residues are either quaternized nitrogen atoms or imidazolium residues. A broad subset of the 28 prepared structures boast single-digit micromolar activity against a panel of eight bacteria that represent Gram-positive, Gram-negative, and resistant strains. Importantly, we have identified structure-activity relationships that highlight a set of four compounds (PHL-6,8, PHL-8,6, PHL-4-imid-8, and PHL-6-imid-6) that have MIC values generally ≤2 μM, as well as therapeutic indices (using red blood cell lysis as a proxy) of 32-250. Interestingly, a series of compounds with a single additional carbon per side chain shows marginally better potency (average MIC = 1 μM) but a significant jump in eukaryotic toxicity, dropping TI levels significantly. These observations reinforce the importance of amphiphilic balance in the development of disinfectant structures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.